Boston An independent LDT provider

Press releases

August 19, 2021 | REGULATORY

Immunovia Publishes Report for the Second Quarter 2021

Read press release
May 6, 2021 | REGULATORY

Annual General Meeting – Immunovia AB

Read press release
April 28, 2021 | REGULATORY

Immunovia Reports Interim Report January – March 2021

Read press release
April 21, 2021 | REGULATORY

Immunovia presents update on US market size for IMMray™ PanCan-d in the familial/hereditary risk group

Read press release
March 31, 2021 | REGULATORY

KALLELSE TILL ÅRSSTÄMMA I IMMUNOVIA AB

Read press release
March 29, 2021 | REGULATORY

Immunovia reports positive results of the blinded clinical validation of IMMray[TM] PanCan-d blood test in USA

Read press release
March 29, 2021 | REGULATORY

Immunovia reports improved test performance of IMMray[TM] PanCan-d in detecting early stage pancreatic cancer in high risk symptomatic patients

Read press release
March 12, 2021 | REGULATORY

Immunovia publishes the annual report for the financial year 2020

Read press release
February 17, 2021 | REGULATORY

Immunovia Full Year Report 2020

Read press release
December 2, 2020 | REGULATORY

Invitation to telephone conference in response to Dagens Industri’s article published on December 1

Read press release
November 17, 2020 | REGULATORY

Chief Executive Officer, Patrik Dahlen Buys Immunovia Shares

Read press release
November 12, 2020 | REGULATORY

Immunovia Reports Third Quarter Interim Report January – September 2020

Read press release
1 2 3 4 13